1-4 of 4
T Masaoka
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Long-term follow-up of minimal residual disease in leukemia patients by monitoring WT1 (Wilms tumor gene) expression levels

K Inoue, H Ogawa, T Yamagami, T Soma, Y Tani, T Tatekawa, Y Oji, H Tamaki, T Kyo, H Dohy, A Hiraoka, T Masaoka, T Kishimoto, H Sugiyama
Journal: Blood
Blood (1996) 88 (6): 2267–2278.
https://doi.org/10.1182/blood.V88.6.2267.bloodjournal8862267
Published: 1996
Journal Articles

WT1 as a new prognostic factor and a new marker for the detection of minimal residual disease in acute leukemia

K Inoue, H Sugiyama, H Ogawa, M Nakagawa, T Yamagami, H Miwa, K Kita, A Hiraoka, T Masaoka, K Nasu
Journal: Blood
Blood (1994) 84 (9): 3071–3079.
https://doi.org/10.1182/blood.V84.9.3071.3071
Published: 1994
Journal Articles

Expression of the interleukin-6 (IL-6), IL-6 receptor, and gp130 genes in acute leukemia

K Inoue, H Sugiyama, H Ogawa, T Yamagami, T Azuma, Y Oka, H Miwa, K Kita, A Hiraoka, T Masaoka
Journal: Blood
Blood (1994) 84 (8): 2672–2680.
https://doi.org/10.1182/blood.V84.8.2672.2672
Published: 1994
Journal Articles

Methotrexate, cyclosporine, or both to prevent graft-versus-host disease after HLA-identical sibling bone marrow transplants for early leukemia?

O Ringden, MM Horowitz, P Sondel, RP Gale, JC Biggs, RE Champlin, HJ Deeg, K Dicke, T Masaoka, RL Powles
Journal: Blood
Blood (1993) 81 (4): 1094–1101.
https://doi.org/10.1182/blood.V81.4.1094.1094
Published: 1993